Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ALEC-04 by Alentis Therapeutics for Nasopharyngeal Cancer: Likelihood of Approval
ALEC-04 is under clinical development by Alentis Therapeutics and currently in Phase II for Nasopharyngeal Cancer. According to GlobalData, Phase...
ALEC-04 by Alentis Therapeutics for Oral Cavity (Mouth) Cancer: Likelihood of Approval
ALEC-04 is under clinical development by Alentis Therapeutics and currently in Phase II for Oral Cavity (Mouth) Cancer. According to...
ALEC-04 by Alentis Therapeutics for Hypopharyngeal Cancer: Likelihood of Approval
ALEC-04 is under clinical development by Alentis Therapeutics and currently in Phase II for Hypopharyngeal Cancer. According to GlobalData, Phase...